Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07089550Recruiting
PSMA PET scans to track treatment response in advanced prostate cancer
This study uses a special type of scan called a PSMA PET to see how well different prostate cancer treatments are working. It is for people with advanced prostate cancer who are about to start or change systemic therapy.
Bologna, ItalyAges 18 years+ - NCT07614776RecruitingPhase 3
New Eye Injection Treatment for Age-Related Macular Degeneration
This study tests whether a new eye injection called ABP 938 works as well as or better than the current standard treatment (Eylea) for wet age-related macular degeneration—a condition that causes vision loss in the center of your sight. You would receive injections into your eye every month for a year.
Fullerton, CaliforniaAges 50 years+ - NCT05710627Recruiting
Testing TENEX for hip pain from greater trochanteric pain syndrome
This trial studies whether TENEX (a minimally invasive procedure) can reduce hip pain caused by greater trochanteric pain syndrome (GTPS). It is for people who have tried non-surgical treatments for at least 6 months without enough relief, and who have confirmed GTPS on imaging (MRI or CT).
The Bronx, New YorkAges 30–90 - NCT06321198Recruiting
Modified stem cells for severe graft-versus-host disease
This trial tests a new type of stem cell therapy (iMSC) for people with steroid-resistant acute graft-versus-host disease (aGVHD), a serious complication after a stem cell transplant. The goal is to see if it's safe and might help control the disease.
Hefei, AnhuiAges 4–70 - NCT07311369RecruitingPhase 2
Testing a new pain tablet after abdominal surgery
This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.
Changsha, HunanAges 18–75 - NCT07658443Enrolling by invitation
Evaluating DFPP for microplastic reduction
This trial tests whether DFPP, a blood filtration treatment you may already be receiving, can reduce microplastics in your blood. If you are already scheduled for DFPP, you may help us learn more about its benefits.
ObergünzburgAges 18–80 - NCT07083999Recruiting
Fertility support for women 32 to 38 trying to conceive
This study looks at how the Ovosicare® Fertility supplement affects fertility in women between 32 and 38 years old who have been trying to get pregnant for at least six months. It's a way to see if this product can help improve your chances of conceiving.
Sitges, BarcelonaAges 32–38 - NCT06332742Recruiting
Herbal formula for low egg reserve in women ages 25–45
This trial tests a Chinese herbal formula called Qingxin Zishen Decoction to see if it can improve egg health and hormone levels in women with low ovarian reserve. It may be an option if you are between 25 and 45 and have not had surgery or hormone treatments recently.
Nanjing, JiangsuAges 25–45 - NCT07107633RecruitingPhase 2
Imaging test for cancer spread in the abdomen
This trial tests a special imaging injection to see if it can better detect cancer that has spread to the lining of the abdomen in people with stomach or bowel cancer. If you are scheduled for surgery to remove or explore the cancer, this scan might help your doctor plan the best treatment.
ShanghaiAges 18 years+ - NCT07084545Recruiting
Cataract surgery lens for people with prior laser vision correction
This trial tests a special lens (CT LUCIA) for people who had laser vision correction in the past and now need cataract surgery. It aims to see how well the lens works in these patients.
Sugar Land, TexasAges 18 years+ - NCT07493239Recruiting
Testing a supplement for knee pain and mobility
This trial studies whether a dietary supplement called MyCondro™ can improve joint health and movement in people with knee osteoarthritis. You will take the supplement for up to 16 weeks and track your symptoms using a smartphone app.
Los Angeles, CaliforniaAges 45 years+ - NCT06021483Recruiting
Observing safety and effectiveness of Zepzelca for lung cancer
This study tracks how safe and effective the drug Zepzelca (a chemotherapy) is for people with advanced small cell lung cancer that has not responded to earlier platinum-based chemo. It allows patients to receive the drug as part of their normal care while researchers collect data.
SeoulAges 19 years+ - NCT07484724RecruitingPhase 2
JS212 combination therapy for advanced esophageal cancer
This trial tests a new combination of drugs (JS212 plus another medicine) for people with advanced esophageal squamous cell carcinoma who have not had prior treatment. It aims to see if the combination is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT07063602Recruiting
Comparing nerve block methods for pain after lung surgery
This study compares two ways of giving a paravertebral nerve block (an injection near the spine to numb the chest) to control pain after a type of lung surgery called VATS. It aims to find the best approach for reducing pain and the need for stronger pain medicines.
Montreal, QuebecAges 18 years+ - NCT07127224Recruiting
Predicting recovery with smell tests in coma
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
Paris, GHU Psychiatrie Et NeurosciencesAges 18 years+ - NCT07568730RecruitingPhase 2
Testing Lacripep eye drops for neurotrophic keratitis
This trial tests whether a new eye drop called Lacripep can help treat neurotrophic keratitis, a rare eye condition where the cornea loses sensation and can become damaged. The study compares Lacripep to a placebo (inactive) drop to see if it improves corneal healing and vision.
Carmel, IndianaAges 18 years+ - NCT07600632Recruiting
Hip Replacement Surgery Outcomes Using Short Stem
This study reviews results from hip replacement surgery using a special short implant inserted through a small front-of-hip incision. Researchers want to understand how well this approach works and how long the implant lasts.
BolognaAges 18 years+ - NCT07039578RecruitingPhase 2
Study of CM336 for light-chain amyloidosis
This trial tests a new injection called CM336 for people with light-chain amyloidosis that has come back or not responded to other treatments. It aims to see if the drug is safe and effective.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06695793Recruiting
Comparing stitches for uterine closure after c-section
This study compares three different ways of stitching the uterus closed after a planned c-section. The goal is to see which method helps the uterus heal best.
CairoAges 18–35 - NCT07542808RecruitingPhase 2/Phase 3
Stem cell treatment vs. hyaluronic acid for knee arthritis
This study tests whether an injection of stem cells (special cells that can help repair tissue) works better than a standard hyaluronic acid injection for knee osteoarthritis pain. Both treatments are injected into the knee to reduce pain and improve function.
Abu DhabiAges 18 years+ - NCT07122128Recruiting
Saliva test for early oral cancer in people with OSMF
This trial studies whether a simple saliva test can help detect oral cancer early in people who have a condition called oral submucous fibrosis (OSMF), which raises the risk of oral cancer. Healthy volunteers and those with OSMF or proven oral cancer are needed.
Jāmshoro, SinchAges Any age - NCT06709534Recruiting
Exercise program for gynecologic cancer survivors
This study tests a personalized at-home exercise program designed for gynecologic cancer survivors who have finished treatment. The goal is to see if it can help you feel better and improve symptoms.
Atlanta, GeorgiaAges 18 years+ - NCT07459751RecruitingPhase 2/Phase 3
A study of HLX43 alone or with HLX07 vs docetaxel for advanced squamous lung cancer
This trial tests a new drug called HLX43, given alone or with HLX07, against the standard chemo docetaxel for people with a type of advanced lung cancer called squamous non-small cell lung cancer. It's for patients who have already tried and not responded to platinum chemo and immunotherapy.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06959082RecruitingPhase 2
Testing an experimental drug with chemoradiation for head and neck cancer
This trial tests an experimental drug called VS-101 combined with standard radiation and chemotherapy for people with advanced head and neck cancer that hasn't been surgically removed. The goal is to see if adding this drug helps the treatment work better while keeping side effects manageable.
New Haven, ConnecticutAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.